Cholesterol and Abeta aggregation.
Regarding deposition of amyloid beta-protein (Abeta) in brains with Alzheimer's disease (AD), we previously identified a novel Abeta species that strongly binds to GM1 ganglioside (GM1) in human brains that exhibit early pathological changes of AD. We hypothesized that Abeta undergoes conformational alteration through its binding to GM1 and acts as a seed. We recently found that an increase in the cholesterol concentration in host membranes markedly accelerates Abeta binding to GM1. We then investigated whether the cholesterol concentration in neuronal membranes could be altered under biological conditions that are associated with risk factors for AD development. We attempted to determine the distribution of cholesterol in the synaptic plasma membranes (SPMs) of human apolipoprotein E (apoE)-knock-in mice and found that the cholesterol concentration in the exofacial leaflet of SPMs of the human apoE4-knock-in mice was approximately twice that of human apoE3-knock-in mice. The results of our studies suggest that an increase in the cholesterol concentration in the neuronal membranes accelerates Abeta aggregation through the formation of an endogenous seed.
Yanagisawa
K
K
Department of Dementia Research, National Institute for Longevity Sciences, Morioka, Obu, Japan. katuhiko@nils.go.jp
D000375:Aging; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D002462:Cell Membrane / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism*; D016537:Gangliosidosis, GM1 / Q000378:metabolism*; D006801:Humans; D008081:Liposomes; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D058225:Plaque, Amyloid; D011485:Protein Binding; D020033:Protein Isoforms; D013570:Synaptic Membranes / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D001057:Apolipoproteins E; D008081:Liposomes; D020033:Protein Isoforms; D002784:Cholesterol